Deciphera Pharmaceuticals' Series B - II Round

Deciphera Pharmaceuticals raised a round of funding on January 05, 2016. Investors include SV Health Investors.

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the rate and/or durab…

Articles about Deciphera Pharmaceuticals' Series B - II Round: